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Abstract
Background
Increasingly, patients with multiple chronic conditions are being managed in patient-cen-
tered medical homes (PCMH) that coordinate primary and specialty care. However, little is
known about the types of providers treating complex patients with diabetes and compen-
sated cirrhosis.
Objective
We examined the mix of physician specialties who see patients dually-diagnosed with dia-
betes and compensated cirrhosis.
Design
Retrospective cross-sectional study using 2000–2013 MarketScan® Commercial Claims
and Encounters and Medicare Supplemental Databases.
Patients
We identified 22,516 adults ( 18 years) dually-diagnosed with diabetes and compensated
cirrhosis. Patients with decompensated cirrhosis, HIV/AIDS, or liver transplantation prior to
dual diagnosis were excluded.
Main Measures
Physician mix categories: patients were assigned to one of four physician mix categories:
primary care physicians (PCP) with no gastroenterologists (GI) or endocrinologists
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(ENDO); GI/ENDO with no PCP; PCP and GI/ENDO; and neither PCP nor GI/ENDO.
Health care utilization: annual physician visits and health care expenditures were assessed
by four physician mix categories.
Key Results
Throughout the 14 years of study, 92% of patients visited PCPs (54% with GI/ENDO and
39% with no GI/ENDO). The percentage who visited PCPs without GI/ENDO decreased
22% (from 63% to 49%), while patients who also visited GI/ENDO increased 71% (from
25% to 42%).
Conclusions
This is the first large nationally representative study to document the types of physicians
seen by patients dually-diagnosed with diabetes and cirrhosis. A large proportion of these
complex patients only visited PCPs, but there was a trend toward greater specialty care.
The trend toward co-management by both PCPs and GI/ENDOs suggests that PCMH ini-
tiatives will be important for these complex patients. Documenting patterns of primary and
specialty care is the first step toward improved care coordination.
Introduction
Increasingly, patients with multiple chronic conditions are beingmanaged in patient-centered
medical homes (PCMH) [1,2] that seek to provide comprehensive, patient-centered, and coor-
dinated care [3]. Central to the PCMH is coordinating primary and specialty care. Despite the
increasing number of patients with multiple chronic conditions [4], little is known about the
mix of PCPs and specialists treating patients other than cancer survivors. Before medical care
can be coordinated, it is vital to understand the types of providers treating medically complex
patients with multiple chronic diseases.
Cirrhosis is the 11th leading cause of death in the United States [5], with the mortality rate
increasing 40% in the past two decades [6]. Cirrhosis has two stages: compensated (patients
with preserved liver function and no major complications) and decompensated (patients with
major complications that require more intensive care). Because early cirrhosis is often asymp-
tomatic, many patients are unaware of their disease [7] and, without proper care, are at risk for
developing complications. A common comorbidity of cirrhosis is diabetes, which afflicts 28–
40% of patients with compensated cirrhosis [8–10]. Patients dually-diagnosedwith diabetes
and compensated cirrhosis have a higher risk of developing decompensation events, including
ascites, spontaneous bacterial peritonitis, variceal bleeding, hepatocellular carcinoma, and
acute renal failure [10].
Patients with both diabetes and compensated cirrhosis may benefit from beingmanaged by
a mix of PCPs and specialists from gastroenterology and endocrinology. Several studies provide
insights into the benefits of receiving care from both specialists and PCP among diabetes
patients with chronic kidney disease [11,12], tuberculosis [13] and cancer [14–18]; however,
little is known about patients dually-diagnosedwith diabetes and compensated cirrhosis [19].
In addition, access to care may also influence on how these complex patients visited different
physician specialty. Our study seeks to examine what physician specialties treat patients
dually-diagnosedwith diabetes and compensated cirrhosis between 2000 and 2013.
Physician Specialties Treating Diabetes and Cirrhosis
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Methods
Data Source and Sample
MarketScan1 Commercial Claims and Encounters and Medicare Supplemental Databases
(Copyright 2015 Truven Health Analytics Inc. All Rights Reserved)between 2000 and 2013
were used for this retrospective cross-sectional study. Enrollees in MarketScan1 included
employees insured by employer-sponsored plans and their dependents, as well as Medicare-eli-
gible retirees with employer-provided Medicare Supplemental Plans. The sample included all
patients 18 years of age or older who were enrolled for at least 6 months before and after the
first date of being dual diagnosedwith diabetes and compensated cirrhosis (Fig 1). The first
Fig 1. Patient flow for selecting dually diagnosed patients.
doi:10.1371/journal.pone.0165574.g001
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dual diagnosis date of diabetes and compensated cirrhosis was defined as either the first date of
diabetes after a diagnosis of compensated cirrhosis, or vice versa. Both diabetes and compen-
sated cirrhosis were defined using the International Classification of Diseases, 9th Revision,
ClinicalModification (ICD-9-CM). Using data from the Outpatient ServicesTables and Inpa-
tient Admissions Tables, Diabetes was defined as either: 1) two or more different dates of ser-
vice for a diabetic-related diagnosis (ICD-9-CM code: 250.xx) from the Outpatient Services
Table or 2) at least one inpatient encounters with an ICD-9-CM code for diabetes [20]. Com-
pensated cirrhosis was defined as alcoholic cirrhosis of the liver (ICD-9-CM code: 571.2), cir-
rhosis (ICD-9-CM code: 571.5), and biliary cirrhosis (ICD-9-CM code: 571.6) [21]. We
excluded patients with decompensated cirrhosis (ICD-9-CM code: 789.59, 567.23, 456.00,
456.10, 456.2x, 572.20, 070.2x, 070.40, 070.44, 070.49, 070.60), acute renal failure (ICD-9-CM
code: 584.xx), or hepatocellular carcinoma (ICD-9-CM code: 155.xx) diagnosed prior to the
first dual diagnosis date. In addition, to avoid misclassification, patients who were prescribed
an encephalopathy drug (Lactulose and Rifaxamin), had a diagnosis of HIV (ICD-9-CM code:
042.xx-044.xx), or had a liver transplantation (ICD-9-CM code: V42.7, ICD-9 procedure: 50.5,
or CPT code: 47135, 47136) prior to the first dual diagnosis date were also excluded. The end
of the study periodwas defined as the: 1) first drop-out date; 2) date of a serious complication
(i.e. decompensation event, hepatocellular carcinoma, and acute renal failure); or 3) end of the
study period (December 31, 2013). The study was exempted by University of North Carolina at
Chapel Hill Institutional ReviewBoard.
Type of Physicians
Physicians who practiced in outpatient settings were identified using the “Provider Type” from
the MarketScan Outpatient ServicesTable. Gastroenterologists (GI) and endocrinologists
(ENDO)were defined as physicians in these specialties. Because there was no category for
PCP, we used a definition used previously [14–17]: family practice, geriatric medicine, obstet-
rics/gynecology, internal medicine not elsewhere classified (NEC), medical doctor (NEC), and
multi-specialty group practice.We categorized patients into four categories based on the physi-
cian mix visited: (1) PCP with no GI/ENDO, (2) GI/ENDOwith no PCP, (3) both PCP and
GI/ENDO, and (4) neither PCP nor GI/ENDO (Fig 1). We summed physician encounters by
specialty in each year from 2000 to 2013.
Physician Density
Previous studies have found that patients residing in higher physician density areas had better
access to PCPs and specialists [22–24]. We focused on density of PCPs, GI/ENDOs, and other
physicians. MarketScan contain enrollees’ five-digit Federal Information Processing Standard
(FIPS) codes between year 2000 and 2010, but was dropped afterward due to privacy concerns.
For patients who had their first dual-diagnosis of diabetes and compensated cirrhosis after
2011, metropolitan statistical area (MSA) was used to determine whether patients resided in a
metropolitan area, as well as their state and county. Patients who resided in non-metropolitan
areas after 2011 did not have county and state information and were dropped. The five-digit
FIPS codes for 2001–2010 data, as well as state and county (linked throughMSA) for 2011–
2013 data, were identifiedwith hospital referral regions (HRRs) through the Dartmouth Atlas
Project (www.dartmouthatlas.org). The Dartmouth Atlas Project identified 306 HRRs based
on where Medicare patients were admitted for tertiary care for major cardiovascular surgeries
[25]. Density of PCP, GI, ENDO, and other specialties per 100,000 residents in each HRR were
only provided in 1996, 2006, and 2011. We linked the physician density with the closest year:
2000 and 2001 were linked with physician density in 1996; 2002–2008 with physician density
Physician Specialties Treating Diabetes and Cirrhosis
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in 2006; and 2009–2013 with physician density in 2011. If multiple HRRs were linked to single
patient, weighted physician densities based on the total population in each HRR were
calculated.
Health Care Utilization
Annual physician visits and annual health care expenditures for each patient were used as indi-
cators of health care utilization. Both variables came from the MarketScan Outpatient Services
Table. Physician visits were summed for each physician mix category during the observation
period. Total health care expenditures were the sum of deductible, coinsurance, coordination
of benefits and other savings, and the net payments from each outpatient visit. In addition,
total health care expenditures were adjusted by inflation using the Medical Care Consumer
Price Index in 2013 dollars. Average physician visits and health care expenditures per patient
per year were reported.
Covariates
Demographic variables, including age, gender, geographic region, and urban/rural residence
were identified through the Annual Enrollment Summary Table. The Elixhauser Comorbidities
index [26,27] was defined for the six months prior to the first dual diagnosis date. To avoid col-
linearity, diseases related to liver disease and diabetes were excluded when calculating the Elix-
hauser Comorbidity Index; the remaining 28 comorbidities were summed (0–28). Because
socioeconomic status (SES) was not available in the database, area-level median income was
used as a proxy. Area-level median income provided by the Small Area Estimates Branch, U.S.
Census Bureau was linked through five-digit FIPS code between 2000 and 2010 and MSA code
between 2011 and 2013.
Data Analysis
Our analysis focused on investigating the characteristics that affect dually-diagnosedpatients’
use of physician mix categories. We first examined patient characteristics, the distribution of
visits to physician mix categories, and the number of physician encounters between 2000 and
2013. Patient encounters were analyzed separately for additional information.We then com-
pared the percentage and average number of annual visits to each physician specialty by physi-
cian mix category. Time trends for the percentage and the number of visits for physician mix
categories were analyzed. Furthermore, to understand the characteristics that affect patients’
physician mix category, a multinomial probit model was estimated to compare the odds of vis-
iting different physician mix categories, controlling for age, gender, geographic location,
urban/rural residence, physician density, number of comorbidities, and area-level median
income. Marginal effects on the probability of visiting each physician mix category and confi-
dence intervals (CI) were calculated and reported based on the delta method. A p-value< 0.05
was considered statistically significant. All analyses were conducted using SAS for Windows,
Version 9.4 (SAS Institute Inc, Cary, NC, USA) and STATA 14.0 (STATA Corp, College Sta-
tion, TX, USA).
Results
The 22,516 patients (47,985 patient-years) in the final sample (Fig 1) had 1,151,542 encounters
during the 14-year study period.Approximately half of patients (54.0%) were male, 25.6%
were over 65 years of age, 86.4% resided in urban areas; patients had a mean of 1.88 comorbidi-
ties besides diabetes and cirrhosis (Table 1). In addition, patients had a mean of 18.7 months of
Physician Specialties Treating Diabetes and Cirrhosis
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observation time (median of 11.2 months). Patients who visited GI/ENDOwith no PCP had
the fewest comorbidities; patients who visited PCPs, with or without GI/ENDO, had the most
comorbidities.
During the 14-year study, 92.5% of patients visited a PCP (53.8% visited PCP and GI/
ENDO and 38.7% visited PCP with no GI/ENDO) and 58.6% visited any GI/ENDO(53.8% vis-
ited PCP/GI/ENDOand 4.8% visited GI/ENDOwith no PCP). In addition, 2.7% of patients
did not visit any PCP, GI, and/or ENDO. Between 2003 and 2006, the distribution of physician
mix changed from visiting PCP only to both PCPs and specialists (Fig 2). Overall, the number
of patients who visited both PCPs and specialists (GI and ENDO) increasedmore than 70%
between 2000 (24.7%) and 2013 (42.2%). About 4% of patients in any given year did not visit
either PCP or GI/ENDO, but the percentage decreased 21% from 2000 to 2013. Overall, a large
proportion of patients visited PCPs only in any given year throughout the 14 years of
observation.
At the encounter-level, 57.1% of all encounters were with PCPs, 5.9% of encounters were
with GIs, and only 3.0% of encounters were with ENDOs. Other provider encounters included
cardiovascular disease specialists (6.4%), oncology (4.7%), and ophthalmology (3.4%). The
Table 1. Descriptive distribution of patients who were dually diagnosed with compensated cirrhosis and diabetes by physician mix category,
MarketScan 2000–2013.
Total
(n = 22,516)
PCP with no GI/ENDO
(n = 8,717)
GI/ENDO with no PCP
(n = 1,078)
PCP and GI/ENDO
(n = 12,110)
Other physician
(n = 611)
Total dual diagnosed patients
(%)
38.7 4.8 53.8 2.7
Female (%) 46.0 43.3 38.2 49.0 39.8
Age group (%)
Under 40 3.5 3.9 4.3 3.1 3.6
40–44 4.6 4.9 4.4 4.3 4.4
45–49 9.3 9.5 10.9 9.0 10.8
50–54 16.6 15.2 16.4 17.7 14.7
55–59 21.6 19.4 22.2 23.2 20.0
60–64 18.8 18.7 21.4 18.5 23.1
65+ 25.6 28.5 20.4 24.1 23.4
Region (%)
Northeast 13.9 12.3 17.4 14.7 14.7
Midwest 28.3 32.8 18.1 26.4 21.4
South 51.5 47.1 60.2 53.6 58.4
West 6.2 7.7 4.3 5.3 5.4
Rural area (%) 38.7 4.8 53.8 2.7
Urban area (%) 46.0 43.3 38.2 49.0 39.8
Elixhauser Comorbidity Index
(mean ± SD)
1.9 ± 1.7 2.0 ± 1.8 1.7 ± 1.6 1.8 ± 1.7 2.2 ± 1.8
Median income in 10K
(mean ± SD)
5.1 ± 1.3 5.0 ± 1.2 5.2 ± 1.3 5.1 ± 1.3 5.0 ± 1.2
Observed length in months
(mean ± SD)
18.7 ± 21.5 16.2 ± 19.7 5.5 ± 7.7 22.3 ± 23.0 5.4 ± 8.6
Number of physician visits
(mean ± SD)
51.1 ± 77.4 41.7 ± 67.3 12.2 ± 33.0 63.6 ± 85.4 8.9 ± 23.2
Healthcare expenditure in 1K*
(mean ± SD)
4.2 ± 15.9 3.3 ± 9.0 1.1 ± 2.8 5.2 ± 20.2 1.1 ± 4.4
*Healthcare expenditures were adjusted by inflation using the Medical Care Consumer Price Index in 2013 dollars.
doi:10.1371/journal.pone.0165574.t001
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remaining provider encounters included a diverse group of specialists, each representing less
3% of all encounters (Table 2).
The trend of annual physician visits was very similar across physician mix categories (Fig
3). On average, patients who visited both PCP and GI/ENDOhad the highest number of total
physician visits, followed by patients who visited PCP with no GI/ENDO. The same pattern
can be found in total health expenditures, but the health care expenditure increased steadily
over the past decade. Patients who visited PCPs only had the fewest comorbidities; while the
number of comorbidities among patients who visited both PCP and GI/ENDOwere only
slightly higher than the PCP only group (Fig 4). The average number of comorbidities steadily
increased after 2002.
Patients had a mean of 15.0 visits to any PCP, 4.4 visits to any GI/ENDO, and 7.2 visits to
any other physicians throughout the study period (Fig 5). Patients who were in PCP/GI/ENDO
group had slightly lower mean number of PCP visits than the PCP with no GI/ENDOgroup in
every year of estimate, but had the highest mean number of visits to other physician than the
rest of the physician mix categories. Among patients who had visited any GI/ENDO, the mean
number of visits was similar between those with and without a PCP visit.
After adjusting for patient characteristics and physician density, male patients, patients with
a higher number of comorbidities and lower median incomes had a higher probability of visit-
ing PCPs with no GI/ENDO;while female patients, those with fewer comorbidities, and those
with higher median incomes had higher probability of visiting the specialist with or without
Fig 2. Distribution of physician mix categories among dually diagnosed patients.
doi:10.1371/journal.pone.0165574.g002
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PCP (Table 3). Moreover, patients who resided in higher PCP density areas tend to visit PCP
more than any other specialties, while patients who resided in higher GI/ENDOdensity area
had higher probability of visiting any GI/ENDOand lower probability of visiting any PCP.
Finally, patients who resided in rural areas had statistically significant lower probability of visit-
ing any GI/ENDOspecialist.
Discussion
This is the first national study to examine patterns of outpatient care for patients with dually-
diagnosed diabetes and compensated cirrhosis, a group with high and costly health care utiliza-
tion. These complex patients may be best managed by both outpatient PCPs and specialist phy-
sicians. Previous studies have shown that the role of PCPs in managing patients with
Table 2. Distribution of total physician encounters by specialties, 2000–2013.
n %
Total 1,151,542
Primary Care Physician 657,604 57.1
Cardiovascular Dis/Cardiology 73,235 6.4
Gastroenterology 68,370 5.9
Oncology 54,480 4.7
Ophthalmology 38,715 3.4
Endocrinology & Metabolism 35,196 3.1
Hematology 30,887 2.7
Emergency Medicine 28,512 2.5
Dermatology 22,517 2.0
Urology 21,299 1.8
Rheumatology 16,158 1.4
Pulmonary Disease 15,111 1.3
Neurology 13,393 1.2
Nephrology 13,326 1.2
Physical Medicine & Rehab 12,842 1.1
Otolaryngology 11,612 1.0
Psychiatry 10,271 0.9
Infectious Disease 8,216 0.7
Allergy & Immunology 6,976 0.6
Hospitalist 2,923 0.3
Pediatrician (NEC) 2,296 0.2
Critical Care Medicine 2,209 0.2
Plastic/Maxillofacial Surgery 2,176 0.2
Osteopathic Medicine 1,994 0.2
Preventative Medicine 354 0.0
Proctology 263 0.0
Pediatric Specialist (NEC) 183 0.0
Pediatric Orthopaedics 178 0.0
Neonatal-Perinatal Medicine 105 0.0
Sports Medicine (Pediatrics) 59 0.0
Palliative Medicine 45 0.0
Genetics 34 0.0
Pediatric Urology 3 0.0
doi:10.1371/journal.pone.0165574.t002
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compensated cirrhosis was to identify risk factors, improve quality and length of life, and pre-
vent patients from complications [28]. Specialists traditionally treat the complications and
select patient candidates for liver transplantation when necessary [28]. One study found that
patients had better outcomes whenmanaged by both PCPs and GIs when admitted to hospital
for a decompensation event [29]. Another study found that local access to subspecialty care
increases the chance of patients receiving a liver transplant [24]. However, we are not aware of
Fig 3. Average number of annual health care utilization among dually diagnosed patients, by physician mix category.
doi:10.1371/journal.pone.0165574.g003
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any studies investigating the mix of physician specialties treating patients with diabetes and
compensated cirrhosis.
We found that more than 90% of these patients visited PCPs; 39% of all patients only visited
PCPs. When examining trends in the mix of physician visits, more than half of our sample vis-
ited PCPs but not any specialists each year. Notably, the percentage of patients visiting a PCP
decreased 22% between 2000 (63%) and 2013 (49%), while the share of patients who visited
Fig 4. Average age and number of comorbidities by physician mix categories by year.
doi:10.1371/journal.pone.0165574.g004
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both PCPs and specialists increased by over 70% during the same period (from 24.7% in 2000
to 42.2% in 2013). One explanation for this shift may be the increasing emphasis on the
PCMH: if patients with diabetes are diagnosedwith compensated cirrhosis are referred to the
GI, it could explain the increasing percentage of patients visiting both PCPs and GIs. As these
Fig 5. Average number of annual visits to physician specialties among dually diagnosed patients, by physician mix category.
doi:10.1371/journal.pone.0165574.g005
Physician Specialties Treating Diabetes and Cirrhosis
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patients increasingly visit both PCPs and specialists, the PCMH becomes critical to coordinate
care. Several studies have found that the PCMHmodel was able to successfully reduce cost and
ED utilization only among patients with complex chronic conditions [30,31]. Therefore, the
PCMH and other coordinated care models may be especially critical for complex patients such
as those in our study. Other events that temporally coincide with an increase in subspecialty
care around 2002–3 are the changes to the model for end stage liver disease for liver transplant
organ allocation [32] and the use of pegylated interferon and ribavirin for the treatment of hep-
atitis C [33]. Hence, patients with compensated cirrhosis were more likely to be referred to GI
from PCP after the treatment pattern changes.
The mean number of visits to PCPs was about ten times higher than to GI/ENDO.However,
the mix of physicians treating patients in our sample is very different from the mix of physi-
cians found in studies of breast cancer [16] and colorectal cancer [14,15] survivors with comor-
bid chronic diseases. About one quarter of breast cancer survivors visited a PCP, but not an
oncologist, while more than half visited both PCPs and oncologists [16]. Colorectal cancer sur-
vivors tended to visit PCPs but not oncologists, although visiting both PCPs and oncologists
remained the second largest group [14,15]. Our study found that during the 14-year study
period, patients dually-diagnosedwith diabetes and compensated cirrhosis commonly visited
both PCP and specialists, but the distribution changed over time with increased visits to both
PCP and GI/ENDO.
Table 3. Marginal effects on probability and 95% confidence interval of visiting different physician mix categories using multinomial probit
model.
PCP with no GI/ENDO GI/ENDO with no PCP PCP and GI/ENDO Neither PCP nor GI/ENDO
Physician density (per 100K)
PCP 0.0009*** -0.0002* -0.0006* -0.0001
GI/ENDO -0.0269*** 0.0071** 0.0163** 0.0036*
Neither PCP nor GI/ENDO 0.0015*** -0.0001 -0.0013*** -0.0001
Female -0.0474*** -0.0146*** 0.0692*** -0.0072**
Age group
Under 40
40–44 -0.0176 -0.0121 0.0325 -0.0028
45–49 -0.0431* -0.0028 0.0440* 0.0019
50–54 -0.0858*** -0.0098 0.1004*** -0.0048
55–59 -0.0940*** -0.0078 0.1058*** -0.0039
60–64 -0.0590** -0.0011 0.0566** 0.0036
65+ -0.0228 -0.0152 0.0429* -0.0048
Region
Northeast
Midwest 0.0605*** -0.0137* -0.0419** -0.0050
South -0.0168 0.0096 0.0042 0.0030
West 0.0936*** -0.0105 -0.0818*** -0.0013
Rural area 0.0108 -0.0146** 0.0072 -0.0034
Number of comorbidities 0.0132*** -0.0032*** -0.0131*** 0.0031***
Median income in 10K -0.0188*** 0.0017 0.0191*** -0.0020
*P < 0.05
**P < 0.01
***P < 0.001
doi:10.1371/journal.pone.0165574.t003
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Visiting a mix of physician specialties was correlated with increased age, female gender,
physician density, number of comorbidities, and median income in our study. Although
patients who visited a GI/ENDOwith no PCP seem to have the least number of comorbidities
in any given year, they were relatively younger than patients in other physician mix categories.
On the other hand, patients who visited both PCP and GI/ENDOhad the highest total visits
and total expenditures, but their mean number of comorbidities was almost the same as those
who visited PCP only. Patients who lived in rural areas were more likely to see a PCP, while
those residing in urban areas were more likely to see a specialist only. In addition, to take
enrollment months into account, we conducted the sensitivity analysis by including observed
lengths in months as a covariate in the multinomial probit model. The length of enrollment
was positively associated with the probability of seeing both a PCP and GI/ENDO, but the
inclusion of the variable had little qualitatively impact on the other coefficients in the model. If
coordinated care between specialist and PCPs does indeed improve outcomes, geographic
access to care will be an important area for improvement in this population.
Our study had some limitations. First, our sample included only persons who were enrolled
in employer-sponsored plans and/or Medicare Supplemental plans; therefore, our findings
may not generalize to persons who are uninsured or insured with other types of programs. Sec-
ond, some patients were dropped due to incomplete physician density because of the data
structure and data linkage. This was becausewe can only access three years of physician density
from Dartmouth Atlas of Health Care, and these patients were unable to link the correspond-
ing physician density through FIPS and MSA. Third, we lacked county and state information
for patients diagnosed after 2011 and resided in non-metropolitan areas. However, we tried to
obtain the most relevant physician density each year by linking the physician density with the
closest time period. Finally, MarketScan data lack information about important patient charac-
teristics that affect access to care, for example, SES and race/ethnicity. Thus, we were unable to
consider these variables in our analyses. However, we used area-level median income as a
proxy to estimate SES.
The prevalence of and diabetes [34] and cirrhosis [7] alone, and in combination [35,36] is
increasing, as is the morbidity, suffering, and health care costs these patients face. By under-
standing outpatient visit patterns among these patients, we can develop appropriate strategies
to efficientlymanage and improve their health. We found that while the proportion of patients
who visited both PCPs and GI/ENDOs increased dramatically in the past decade, PCPs still
carrymuch of the burden of caring for these complex patients. With the proliferation of the
PCMH, coordinating PCPs and specialists care will be critical. Future research is needed to
determine whether patients with diabetes and compensated cirrhosis could similarly benefit
from coordinated care from PCMHs that involve both PCPs and specialists.
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